Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder

Update Il y a 4 ans
Reference: NCT00143091

Woman and Man

Extract

A six week, fixed dose, double-blind, double-dummy, placebo, and active controlled, multicentre trial to evaluate the safety and efficacy of CP-316,311 in outpatients with major depressive disorder.


Inclusion criteria

  • Depressive Disorder, Major

Links